IL237541A0 - Bolaamphiphilic compounds, compositions and uses thereof - Google Patents

Bolaamphiphilic compounds, compositions and uses thereof

Info

Publication number
IL237541A0
IL237541A0 IL237541A IL23754115A IL237541A0 IL 237541 A0 IL237541 A0 IL 237541A0 IL 237541 A IL237541 A IL 237541A IL 23754115 A IL23754115 A IL 23754115A IL 237541 A0 IL237541 A0 IL 237541A0
Authority
IL
Israel
Prior art keywords
compositions
bolaamphiphilic compounds
bolaamphiphilic
compounds
Prior art date
Application number
IL237541A
Other languages
Hebrew (he)
Other versions
IL237541B (en
Original Assignee
Lauren Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauren Sciences Llc filed Critical Lauren Sciences Llc
Publication of IL237541A0 publication Critical patent/IL237541A0/en
Publication of IL237541B publication Critical patent/IL237541B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL237541A 2012-09-04 2015-03-03 Bolaamphiphilic compounds, compositions and uses thereof IL237541B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261696789P 2012-09-04 2012-09-04
PCT/US2013/057956 WO2014039501A1 (en) 2012-09-04 2013-09-04 Bolaamphiphilic compounds, compositions and uses thereof

Publications (2)

Publication Number Publication Date
IL237541A0 true IL237541A0 (en) 2015-04-30
IL237541B IL237541B (en) 2019-07-31

Family

ID=50237566

Family Applications (3)

Application Number Title Priority Date Filing Date
IL237541A IL237541B (en) 2012-09-04 2015-03-03 Bolaamphiphilic compounds, compositions and uses thereof
IL267888A IL267888B (en) 2012-09-04 2019-07-07 Bolaamphiphilic compounds, compositions and uses thereof
IL280316A IL280316B (en) 2012-09-04 2021-01-20 Bolaamphiphilic compounds, compositions and uses thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL267888A IL267888B (en) 2012-09-04 2019-07-07 Bolaamphiphilic compounds, compositions and uses thereof
IL280316A IL280316B (en) 2012-09-04 2021-01-20 Bolaamphiphilic compounds, compositions and uses thereof

Country Status (5)

Country Link
EP (1) EP2892510A4 (en)
AU (4) AU2013312908A1 (en)
CA (2) CA3233929A1 (en)
IL (3) IL237541B (en)
WO (1) WO2014039501A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3283060A4 (en) * 2015-04-16 2018-12-19 Lauren Sciences LLC Bolaamphiphilic compounds, compositions and uses thereof
JP2022552774A (en) * 2019-08-12 2022-12-20 インテグレイテッド ナノセラピューティクス インコーポレイテッド Lipids that deliver charged substances, formulations thereof, and methods of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162319A0 (en) * 2001-12-04 2005-11-20 Univ Ben Gurion Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
EP1845943A2 (en) * 2005-01-03 2007-10-24 Ben Gurion University of the Negev Research and Development Autority Nano- and mesosized particles comprising an inorganic core, process and applications thereof
AU2010245629A1 (en) 2009-05-04 2012-01-12 Ben-Gurion University Of The Negev Research And Development Authority Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery

Also Published As

Publication number Publication date
AU2018203992A1 (en) 2018-06-21
IL267888A (en) 2019-09-26
AU2020203496B2 (en) 2021-10-28
CA2883784C (en) 2024-05-14
CA3233929A1 (en) 2014-03-13
AU2018203992B2 (en) 2020-02-27
EP2892510A4 (en) 2016-06-01
IL280316B (en) 2021-08-31
AU2020203496A1 (en) 2020-06-18
IL267888B (en) 2021-02-28
IL237541B (en) 2019-07-31
EP2892510A1 (en) 2015-07-15
AU2022200494A1 (en) 2022-02-24
AU2013312908A1 (en) 2015-03-26
CA2883784A1 (en) 2014-03-13
WO2014039501A1 (en) 2014-03-13
IL280316A (en) 2021-03-01

Similar Documents

Publication Publication Date Title
GB201217441D0 (en) Composition
IL233824A (en) 1h-indazole-3-carboxamide compounds, compositions comprising them and uses thereof
HK1216250A1 (en) 8-hydroxy-dihydroergotamine compounds and compositions 8--
GB201200707D0 (en) Composition
EP2903979A4 (en) Novel compounds, their preparation and their uses
EP2878295A4 (en) Composition
GB201218954D0 (en) Composition
EP2874641A4 (en) Glutathione-elevating compositions and uses thereof
IL233682A0 (en) Substituted phenylazole derivatives, compositions comprising same and uses thereof
IL280316B (en) Bolaamphiphilic compounds, compositions and uses thereof
GB201219657D0 (en) Composition
IL237542B (en) Bolaamphiphilic compounds, compositions and uses thereof
GB201206035D0 (en) Composition
EP2837670A4 (en) Fluorobiphenyl-containing composition
IL237540A0 (en) Bolaamphiphilic compounds, compositions and uses thereof
EP2910537A4 (en) Gas-generating-agent composition
EP2910538A4 (en) Gas-generating-agent composition
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
IL237538B (en) Bolaamphiphilic compounds, compositions and uses thereof
GB201219383D0 (en) Composition
GB201218195D0 (en) Composition
IL237539A0 (en) Bolaamphiphilic compounds, compositions and uses thereof
IL235312A0 (en) Taxane compounds, compositions and methods
GB201219065D0 (en) Composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed